Results 151 to 160 of about 1,913,764 (268)

Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher, Charles B. Malpas, Stuart J. McDonald, William T. O’Brien, Craig Despott, Kelly L. Bertram, Matthew P. Pase, Lukas Frontzkowski, Meng Law, Terence J. O’Brien, Lucy Vivash   +10 more
wiley   +1 more source

Cost Analysis of Multidose Drug Dispensing (MDD) System Implementation in a Community Pharmacy in Portugal. [PDF]

Pharmacy (Basel)
Reis A, Jesus Â, Martín ML.
europepmc   +1 more source

The Cost-Benefit Analysis of Implementing Salesforce CRM in Large Enterprises [PDF]

Mahesh Chandra Gupta
openalex   +1 more source

Analysis of the cost of periprosthetic joint infections after total knee and hip arthroplasty and the effect of revision methods on the cost

, 2021
Fatma Yekta Urkmez, İsmihan Sunar, Nihat Tosun, Rahmet Güner, Mehmet A. Taşyaran   +4 more
openalex   +1 more source

​Did a Non‐Medical Biosimilar Switching Policy Cause an Increase in Non‐Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

Arthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang, Sandra Blitz, Nick Bansback, Michael Law, Mark Harrison   +4 more
wiley   +1 more source

Survival and Cost Analysis of Surgical Mitral Valve Replacement With Different Prostheses: A Nationwide Cohort Study in Taiwan. [PDF]

Med Sci Monit
Chien YS, Chung CH, Li JY.
europepmc   +1 more source

Economic evaluation of three domestic bevacizumab biosimilars and the original bevacizumab for treating nonsquamous non-small cell lung cancer in china: a cost-effectiveness analysis [PDF]

Yu Zhang, Tianqi Zhou, Nan Wu, Zhaoshi Bai, Jifu Wei, Ning Cai, Silu Xu   +6 more
openalex   +1 more source

A Scoping Review on Artificial Intelligence–Supported Interventions for Nonpharmacologic Management of Chronic Rheumatic Diseases

Arthritis Care &Research, EarlyView.
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah, Alexis Castellanos, Yen Chen, John Piette, Amy Bucher, Susan Murphy   +5 more
wiley   +1 more source

Cost analysis of probiotic/synbiotic supplementation in infants in rural Kenya: a study from the PROSYNK trial. [PDF]

BMJ Paediatr Open
McCallum B, Iwaret Otiti M, Achieng F, Allen S, Worrall E.   +4 more
europepmc   +1 more source

To Zip Through the Cost Analysis of Probabilistic Programs [PDF]

Matthias Hetzenberger, Georg Moser, Florian Zuleger   +2 more
openalex   +1 more source